Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 357

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Survival with Cardiac-Resynchronization Therapy in Mild Heart Failure

Goldenberg, Ilan, Kutyifa, Valentina, Klein, Helmut U., Cannom, David S., Brown, Mary W., Dan, Ariela, Daubert, James P., Estes, N.A. Mark, Foster, Elyse, Greenberg, Henry, Kautzner, Josef, Klempfner, Robert, Kuniss, Malte, Merkely, Bela, Pfeffer, Marc A., Quesada, Aurelio, Viskin, Sami, McNitt, Scott, Polonsky, Bronislava, Ghanem, Ali, Solomon, Scott D., Wilber, David, Zareba, Wojciech, Moss, Arthur J.·2014·New England Journal of Medicine

Abstract

BACKGROUND: The Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy (MADIT-CRT) showed that early intervention with cardiac-resynchronization therapy with a defibrillator (CRT-D) in patients with an electrocardiographic pattern showing left bundle-branch block was associated with a significant reduction in heart-failure events over a median follow-up of 2.4 years, as compared with defibrillator therapy alone. METHODS: We evaluated the effect of CRT-D on long-term survival in the MADIT-CRT population. Post-trial follow-up over a median period of 5.6 years was assessed among all 1691 surviving patients (phase 1) and subsequently among 854 patients who were enrolled in post-trial registries (phase 2). All reported analyses were performed on an intention-to-treat basis. RESULTS: At 7 years of follow-up after initial enrollment, the cumulative rate of death from any cause among patients with left bundle-branch block was 18% among patients randomly assigned to CRT-D, as compared with 29% among those randomly assigned to defibrillator therapy alone (adjusted hazard ratio in the CRT-D group, 0.59; 95% confidence interval [CI], 0.43 to 0.80; P<0.001). The long-term survival benefit of CRT-D in patients with left bundle-branch block did not differ significantly according to sex, cause of cardiomyopathy, or QRS duration. In contrast, CRT-D was not associated with any clinical benefit and possibly with harm in patients without left bundle-branch block (adjusted hazard ratio for death from any cause, 1.57; 95% CI, 1.03 to 2.39; P=0.04; P<0.001 for interaction of treatment with QRS morphologic findings). CONCLUSIONS: Our findings indicate that in patients with mild heart-failure symptoms, left ventricular dysfunction, and left bundle-branch block, early intervention with CRT-D was associated with a significant long-term survival benefit. (Funded by Boston Scientific; ClinicalTrials.gov numbers, NCT00180271, NCT01294449, and NCT02060110.).

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejmoa1401426

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 14 references

Cited by

See all 357

Metadata

Authors
Goldenberg, I., Kutyifa, V., Klein, H. U., Cannom, D. S., Brown, M. W., Dan, A., Daubert, J. P., Estes, N. A. M., Foster, E., Greenberg, H., Kautzner, J., Klempfner, R., Kuniss, M., Merkely, B., Pfeffer, M. A., Quesada, A., Viskin, S., McNitt, S., Polonsky, B., Ghanem, A., Solomon, S. D., Wilber, D., Zareba, W., & Moss, A. J.
Venue
New England Journal of Medicine
Published
2014-05
Volume
370
Issue
18
Pages
1694-1701
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2158671861
Cited by
357
References
14
FWCI
31.59
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Survival with Cardiac-Resynchronization Therapy in Mild Heart Failure. https://app.cochat.ai/papers/10.1056/nejmoa1401426
The paper
Goldenberg, I., Kutyifa, V., Klein, H. U., Cannom, D. S., Brown, M. W., Dan, A., Daubert, J. P., Estes, N. A. M., Foster, E., Greenberg, H., Kautzner, J., Klempfner, R., Kuniss, M., Merkely, B., Pfeffer, M. A., Quesada, A., Viskin, S., McNitt, S., Polonsky, B., . . . Moss, A. J. (2014). Survival with Cardiac-Resynchronization Therapy in Mild Heart Failure. New England Journal of Medicine. https://doi.org/10.1056/nejmoa1401426

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.